120 related articles for article (PubMed ID: 9544429)
21. Effector lymphocyte response to homologous tumor antigens in various stages of malignant disease as monitored by leukocyte adherence inhibition--cell mediated immunity (LAI-CMI).
Tsang PH; Roboz JP; Holland JF; Bekesi JG
Immunol Lett; 1988 Jan; 17(1):63-70. PubMed ID: 3280478
[TBL] [Abstract][Full Text] [Related]
22. Status of circulating immune complexes, IL8 titers and cryoglobulins in patients with dengue infection.
Patra G; Ghosh M; Modak D; Bandopadhyay B; Saha B; Mukhopadhyay S
Indian J Exp Biol; 2015 Nov; 53(11):719-25. PubMed ID: 26669014
[TBL] [Abstract][Full Text] [Related]
23. Prognostic evaluation of cell mediated immunity in leprosy and correlation with clinicopathological status of leprosy patients.
Aziz M; Malik A; Abbas SM; Vasenwala S; Kalam A
Indian J Pathol Microbiol; 1996 Jan; 39(1):5-12. PubMed ID: 8755125
[TBL] [Abstract][Full Text] [Related]
24. Circulating immune complexes in patients with bladder cancer and other malignancies of the urogenital tract.
Kobayashi K; Umeda T; Akaza H; Niijima T; Aikawa T; Tanimoto K
Urol Int; 1984; 39(4):232-5. PubMed ID: 6485183
[TBL] [Abstract][Full Text] [Related]
25. Circulating immune complexes in advanced Hodgkin's disease: qualitative analysis and prognostic significance.
Tomasević Z; Jelić S
Arch Immunol Ther Exp (Warsz); 2000; 48(3):195-200. PubMed ID: 10912625
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of circulating immune complexes in a long-term follow-up of breast cancer patients.
Iaffaioli RV; Bianchin A; Ruggiero G; Pirozzi G; Ungaro A; Totaro G; Gallo C; De Placido S; Pagliarulo C; Bianco AR
Oncology; 1988; 45(5):337-43. PubMed ID: 3412739
[TBL] [Abstract][Full Text] [Related]
27. [Detection of erythrocyte immune function and circulatory immune complex in myasthenia gravis].
Guo F
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Jun; 23(3):133-5, 188. PubMed ID: 2390883
[TBL] [Abstract][Full Text] [Related]
28. Longitudinal follow-up circulating immune complexes of the serum in patients with breast cancer.
Nekulová M; Tomanová J; Lang BA
Neoplasma; 1982; 29(5):573-7. PubMed ID: 7177247
[TBL] [Abstract][Full Text] [Related]
29. Circulating immune complexes in patients with nasopharyngeal carcinoma.
Wolf GT; Wolfe RA
Laryngoscope; 1990 Mar; 100(3):302-8. PubMed ID: 1689798
[TBL] [Abstract][Full Text] [Related]
30. A phase II trial of extracorporeal plasma immunoadsorption of patient plasma with PROSORBA columns for treating metastatic breast cancer.
Fennelly DW; Norton L; Sznol M; Hakes TB
Cancer; 1995 Apr; 75(8):2099-102. PubMed ID: 7697600
[TBL] [Abstract][Full Text] [Related]
31. MUC1 expression and anti-MUC1 serum immune response in head and neck squamous cell carcinoma (HNSCC): a multivariate analysis.
Rabassa ME; Croce MV; Pereyra A; Segal-Eiras A
BMC Cancer; 2006 Oct; 6():253. PubMed ID: 17064405
[TBL] [Abstract][Full Text] [Related]
32. [Isolation and characterization of immune complexes associated with malignant tumors and leprosy].
Segal-Eiras A; Croce MV; Ramos GS; Córsico B
Medicina (B Aires); 1989; 49(2):125-30. PubMed ID: 2640480
[TBL] [Abstract][Full Text] [Related]
33. Circulating immune complexes in Hodgkin's disease.
Akolkar PN; Advani SH; Gothoskar BP
Neoplasma; 1983; 30(1):73-9. PubMed ID: 6835441
[TBL] [Abstract][Full Text] [Related]
34. [Prognostic significance of typical immune reactions in myocardial infarction].
Zemskov AM; Alekhina OD; Zemskov VM; Zemskov MA; Zoloedov VI
Ter Arkh; 2008; 80(1):32-7. PubMed ID: 18326224
[TBL] [Abstract][Full Text] [Related]
35. An overview: antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition.
Flores M; Marti JH; Grosser N; MacFarlane JK; Thomson DM
Cancer; 1977 Feb; 39(2):494-505. PubMed ID: 319891
[TBL] [Abstract][Full Text] [Related]
36. Circulating immune complexes and cell-mediated immunity in patients with hepatitis B virus associated liver diseases.
Kim SA; Lee SI; Choi IH; Shin JS; Uhm JR; Kim SJ; Choi HJ
Yonsei Med J; 1990 Dec; 31(4):347-58. PubMed ID: 2150250
[TBL] [Abstract][Full Text] [Related]
37. Circulating immune complexes in leprosy sera: demonstration of antibodies against mycobacterial glycolipidic antigens in isolated immune complexes.
Yamashita JT; Cruaud P; Papa F; Rotta O; David HL
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):44-50. PubMed ID: 8326180
[TBL] [Abstract][Full Text] [Related]
38. [Clinical significance of circulating immune complexes in patients with metastatic breast cancer].
Krieger G; Kehl A; Bause I; Kneba M; Nagel GA
Klin Wochenschr; 1982 Dec; 60(23):1465-72. PubMed ID: 7154620
[TBL] [Abstract][Full Text] [Related]
39. Elevation of circulating immune complexes and its relationship to alpha-fetoprotein levels in patients with hepatitis B surface antigen-positive hepatocellular carcinoma.
Tsai JF; Tsai JH; Chang WY; Ton TC
Cancer Invest; 1991; 9(2):137-43. PubMed ID: 1713804
[TBL] [Abstract][Full Text] [Related]
40. Clinical evaluation of serum alpha-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinoma.
Tsai JF; Jeng JE; Ho MS; Chang WY; Lin ZY; Tsai JH
Br J Cancer; 1995 Aug; 72(2):442-6. PubMed ID: 7543774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]